Cytek Biosciences Inc
F:8EQ
Cytek Biosciences Inc
F:8EQ
Price:
3.38
EUR
14.19%
Market Cap:
€443.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cytek Biosciences Inc
F:8EQ
|
US |
|
D
|
DigitalOcean Holdings Inc
XMUN:0SU
|
US |
|
VSE Corp
F:VS3
|
US |
|
A
|
Artisan Partners Asset Management Inc
F:AP0
|
US |
|
N
|
Neodecortech SpA
F:FM2
|
IT |
|
U
|
United Overseas Australia Ltd
SGX:EH5
|
MY |
|
B
|
Burckhardt Compression Holding AG
XMUN:B5H
|
CH |
|
P
|
Perusahaan Gas Negara Tbk PT
F:PGB1
|
ID |
|
J
|
JAFCO Group Co Ltd
XMUN:JAF
|
JP |
|
N
|
Northern Trust Corp
F:NT4
|
US |
|
Taskus Inc
NASDAQ:TASK
|
US |
Wall St Price Targets
8EQ Price Targets Summary
Cytek Biosciences Inc
Cytek Biosciences Inc
Wall Street analysts forecast 8EQ stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 8EQ is 5.16 EUR with a low forecast of 4.35 EUR and a high forecast of 6.78 EUR.
Lowest Forecast
Price Target
4.35
EUR
29% Upside
Average Forecast
Price Target
5.16
EUR
53% Upside
Highest Forecast
Price Target
6.78
EUR
101% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8EQ's stock price target?
Price Target
5.16
EUR
5.16
EUR
According to Wall Street analysts, the average 1-year price target for 8EQ is 5.16 EUR with a low forecast of 4.35 EUR and a high forecast of 6.78 EUR.
What is the Revenue forecast for Cytek Biosciences Inc?
Projected CAGR
8%
8%
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 8%.
